Bayer gets USFDA Priority Review for finerenone for type 2 diabetes, CKD Ruchika Sharma16 Jan 2021 11:00 AM ISTWhippany: Bayer has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted its New Drug Application (NDA) and granted...
Family history of kidney disease strongly linked to increased CKD risk Dr Kartikeya Kohli16 Jan 2021 4:00 AM ISTIn a large population-based family study, family history of kidney disease was strongly associated with increased risk of chronic kidney disease.
AstraZeneca gets USFDA Priority Review for Farxiga to treat chronic kidney disease Ruchika Sharma7 Jan 2021 12:00 PM ISTCKD, a condition defined by decreased kidney function, is often associated with a heightened risk of heart disease or stroke, or the need for dialysis...
Relatively high proportion of diabetes patients experience rapid CKD progression: Study Dr. Nandita Mohan6 Jan 2021 4:00 PM ISTAccording to recent research, investigators have observed that a relatively high proportion of patients were observed with disease progression over a...
Stopping RAS inhibitors tied to worse outcomes in patients with chronic kidney disease Dr Kartikeya Kohli31 Dec 2020 4:45 PM ISTSmall studies have suggested that a group of medications called RAS inhibitors may be harmful in persons with advanced chronic kidney disease, and...
Novel MRI contrast agent sidesteps toxic effects of current products Hina Zahid17 Dec 2020 3:45 PM ISTBOSTON - Researchers at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) are developing an alternative MRI contrast agent based...
Role of vitamin K in controlling atherosclerosis and vascular calcification in CKD patients: Review Dr Kartikeya Kohli1 Dec 2020 12:45 PM ISTChronic kidney disease (CKD) is recognized as a major health problem across the world with Global Burden of Disease (GBD) study 2015 ranking chronic...
Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review Dr. Prem Aggarwal27 Nov 2020 12:45 PM ISTHypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...
Sotagliflozin reduces CVD risk in those with diabetes and kidney disease: Study Hina Zahid18 Nov 2020 10:15 AM ISTDALLAS - A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with...
Finerenone reduces risk of cardiac events in Diabetes with CKD: Study Dr Kartikeya Kohli17 Nov 2020 8:38 AM ISTDALLAS - Researchers have found in a large, international clinical trial that novel medication finerenone reduced the rate of death, heart attack,...
Management of osteoporosis in advanced chronic kidney disease: European Consensus Statement Hina Zahid13 Nov 2020 4:00 PM ISTThe European Renal Osteodystrophy (EUROD) Working Group, bringing together expertise from the European Renal Association-European Dialysis and...
Hypertension and Kidney: Choosing the Right Therapeutic Agent for BP Control and Nephroprotection Dr. Arun Shah11 Nov 2020 11:30 AM ISTIn the management of hypertension, the treatment goals need to be dual with equal emphasis – i.e. to reduce the blood pressure levels and provide...
